Proactive Drug Monitoring Versus Clinically Based Dosing for Endoscopic Healing in Pediatric Crohn’s Disease Receiving Infliximab
Dosing based on proactive TDM was superior to clinically based dosing in terms of EH in a randomized controlled trial of pediatric CD. Trial identifier: cris.nih.go.kr: KCT0005190.
Authors
- Jae Sung Ko (ORCID: https://orcid.org/0000-0002-3064-2974)
- Ben Kang (ORCID: https://orcid.org/0000-0002-8516-9803)
- Byung‐Ho Choe (ORCID: https://orcid.org/0000-0001-9899-9120)
- Yiyoung Kwon (ORCID: https://orcid.org/0000-0001-5600-2070)
- Yon Ho Choe (ORCID: https://orcid.org/0000-0003-1525-7688)
- So Mi Lee (ORCID: https://orcid.org/0000-0002-2073-8198)
- Jin Soo Moon (ORCID: https://orcid.org/0000-0001-9760-297X)
- Eun Sil Kim (ORCID: https://orcid.org/0000-0003-2012-9867)
- Tae Yeon Jeon
- Yeoun Joo Lee (ORCID: https://orcid.org/0000-0001-8012-5433)
- Seunghyun Lee (ORCID: https://orcid.org/0000-0003-1858-0640)
- Mi Jin Kim (ORCID: https://orcid.org/0000-0002-4505-4083)
- Yi‐Hsu Ju (ORCID: https://orcid.org/0000-0002-7775-1334)
- Sujin Choi
- Sangjun Sohn
Institutions
- Seoul National University (KR)
- Inha University (KR)
- Samsung Medical Center (KR)
- Kyungpook National University (KR)
- Kangbuk Samsung Hospital (KR)
- Pusan National University Yangsan Hospital (KR)
- Celltrion (South Korea) (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Clinical Gastroenterology and Hepatology
- Published
- 2025-05-14
- DOI
- https://doi.org/10.1016/j.cgh.2025.04.025
- Citations
- 2
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 3.63